Md Tabish Rehman

InstitutionKing Saud University
AddressRiyadh
Saudi Arabia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 2 publications in July 2020
    All Publications
    Bar chart showing 41 publications over 10 distinct years, with a maximum of 14 publications in 2019
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Shamsi S, Anjum H, Shahbaaz M, Khan MS, Ataya FS, Alamri A, Alhumaydhi FA, Husain FM, Rehman MT, Mohammad T, Islam A, Anjum F, Shamsi A. A computational study on active constituents of Habb-ul-aas and Tabasheer as inhibitors of SARS-CoV-2 main protease. J Biomol Struct Dyn. 2021 Mar 24; 1-12. PMID: 33759703.
      Citations:    Fields:    
    2. Shamsi A, Mohammad T, Anwar S, Amani S, Khan MS, Husain FM, Rehman MT, Islam A, Hassan MI. Potential drug targets of SARS-CoV-2: From genomics to therapeutics. Int J Biol Macromol. 2021 Apr 30; 177:1-9. PMID: 33577820.
      Citations: 9     Fields:    Translation:Humans
    3. Rehman MT, AlAjmi MF, Hussain A. Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19. Curr Pharm Des. 2021; 27(33):3577-3589. PMID: 33200697.
      Citations: 7     Fields:    Translation:HumansCells
    4. Hussain I, Hussain A, Alajmi MF, Rehman MT, Amir S. Impact of repurposed drugs on the symptomatic COVID-19 patients. J Infect Public Health. 2021 Jan; 14(1):24-38. PMID: 33341481.
      Citations: 2     Fields:    Translation:Humans
    5. Muteeb G, Alshoaibi A, Aatif M, Rehman MT, Qayyum MZ. Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic. Appl Biol Chem. 2020; 63(1):79. PMID: 33251389.
      Citations: 5     
    6. AlAjmi MF, Azhar A, Owais M, Rashid S, Hasan S, Hussain A, Rehman MT. Antiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19. J Biomol Struct Dyn. 2021 10; 39(17):6676-6688. PMID: 32729392.
      Citations: 1     Fields:    Translation:Humans
    7. Mohammad T, Shamsi A, Anwar S, Umair M, Hussain A, Rehman MT, AlAjmi MF, Islam A, Hassan MI. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy. Virus Res. 2020 10 15; 288:198102. PMID: 32717346.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    8. Shamsi A, Mohammad T, Anwar S, AlAjmi MF, Hussain A, Rehman MT, Islam A, Hassan MI. Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy. Biosci Rep. 2020 06 26; 40(6). PMID: 32441299.
      Citations: 39     Fields:    Translation:Cells